| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2002 | US6444684 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 09/03/2002 | US6444683 17-azolyl steroids useful as androgen synthesis inhibitors |
| 09/03/2002 | US6444682 Base analogues |
| 09/03/2002 | US6444681 Methods and compositions for treating Raynaud's Phenomenon and scleroderma |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444678 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444676 Use of PARP inhibitors in the treatment of glaucoma |
| 09/03/2002 | US6444674 High affinity for the dopamine d3 receptor; schizophrenia, depression, neuroses and psychoses |
| 09/03/2002 | US6444673 Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 09/03/2002 | US6444669 8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments |
| 09/03/2002 | US6444668 Combination regimens using progesterone receptor modulators |
| 09/03/2002 | US6444665 Method for treating pain |
| 09/03/2002 | US6444664 Method for controlling the plasma level of lipoproteins to treat alzheimeris disease |
| 09/03/2002 | US6444662 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease |
| 09/03/2002 | US6444659 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic agents |
| 09/03/2002 | US6444658 Prevention of ovarian cancer by administration of a vitamin D compound |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444655 Galactopyranosides and their use |
| 09/03/2002 | US6444652 ADMINISTERING BETA-L-2'-DEOXYNUCLEOSIDE DERIVATIVES FOR TREATMENT OR PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION IN HOST; telbuvidine for example |
| 09/03/2002 | US6444649 Solid dispersion which comprises sialic acid derivative dispersed in water-soluble macromolecule |
| 09/03/2002 | US6444648 Preventing and/or treating disease caused by leishmaniasis infectious species |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444448 Production of β-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444420 Use of GPR30 receptor ligands to mediate neurotrophic action |
| 09/03/2002 | US6444418 Plasma-like solution |
| 09/03/2002 | US6444233 Triterpene compositions and methods for use thereof |
| 09/03/2002 | US6444231 Catalysis of the transfer of the gamma phosphate of adenosine triphosphate to tyrosine residues of proteins or polypeptides; combined with insulin as an antidiabetic agents |
| 09/03/2002 | US6444227 Radiation or enzyme crosslinked gelatin |
| 09/03/2002 | US6444225 Bioavailability;melting, solidification |
| 09/03/2002 | US6444221 Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
| 09/03/2002 | US6444219 An antiseptic sealed package of solid dry admixed polyvinylpyrrolidone-cinnamic alcohol emulsion, the external surface of emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444201 Therapy for nervous system disorders |
| 09/03/2002 | US6444199 Solid borate-diol interaction products for use in wounds |
| 09/03/2002 | US6444194 Indium photosensitizers for PDT |
| 09/03/2002 | US6444144 Food, feed, drugs and cosmetics |
| 09/03/2002 | US6443976 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 09/03/2002 | CA2263203C 3,6-ketal and enol ether macrolide antibiotics |
| 09/03/2002 | CA2258960C A process for preparing naphthyridones and intermediates |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2234051C Novel isoquinoline derivatives |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2225626C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 09/03/2002 | CA2178085C Glutaramide derivatives |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/03/2002 | CA2096841C Drug delivery porphyrin compositions and methods |
| 09/03/2002 | CA2093557C Antimicrobial composition |
| 09/03/2002 | CA2072949C Stick composition with sodium chloride and stearyl alcohol |
| 09/03/2002 | CA2071345C Feed additive for livestock and feed for livestock |
| 09/03/2002 | CA2065799C Thiazolidinedione derivatives, their production and their use |
| 09/02/2002 | CA2374257A1 Inhalatory compositions of formoterol |
| 09/01/2002 | CA2373596A1 Combination treatment for depression, obsessive compulsive disorder, and psychosis |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002066667A1 Glucosamine and method of making glucosamine from microbial biomass |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066642A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/29/2002 | WO2002066627A1 Regulation of human dipeptidyl peptidase 8 |
| 08/29/2002 | WO2002066617A1 Method for detecting a risk of hypertension and uses thereof |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066490A2 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 08/29/2002 | WO2002066489A2 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 08/29/2002 | WO2002066484A1 Isoxazoline derivatives as anti-depressants |
| 08/29/2002 | WO2002066481A1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 08/29/2002 | WO2002066480A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 08/29/2002 | WO2002066476A1 6-phenylbenzonaphthyridines |
| 08/29/2002 | WO2002066475A2 Tricyclic androgen receptor modulator compounds |
| 08/29/2002 | WO2002066473A1 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site |
| 08/29/2002 | WO2002066472A1 New phenylpiperazines |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066464A1 β-LACTAM COMPOUNDS, PROCESS FOR REPODUCING THE SAME AND SERUM CHOLESTEROL-LOWERING AGENTS CONTAINING THE SAME |
| 08/29/2002 | WO2002066463A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 08/29/2002 | WO2002066462A1 Pyrazole derivatives against tgf overexpression |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066460A1 Chemical compounds |
| 08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066456A2 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 08/29/2002 | WO2002066453A1 Process for the preparation of citalopram |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066437A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 08/29/2002 | WO2002066436A1 Process for preparing 2-(4-chlorobenzolamino) -3-[2(1h) -quinolinon-4-yl]proprionic acid |
| 08/29/2002 | WO2002066435A1 Metal complexes and therapeutic uses thereof |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066429A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |